CAS 635318-26-2

Fórmula: C12H19ClN2O7S2

InChI: InChI=1S/C12H18N2O7S2.ClH/c1-22-3-2-5(13)9(15)14-12(11(18)19)4-23(20,21)8-6(7(8)12)10(16)17;/h5-8H,2-4,13H2,1H3,(H,14,15)(H,16,17)(H,18,19);1H/t5-,6+,7+,8-,12-;/m0./s1

Clave InChI: KTYRTJLEXFSWRJ-LBMFEJOUSA-N

SMILES: CSCC[C@@H](C(=O)N[C@]1(CS(=O)(=O)[C@@H]2[C@H]1[C@H]2C(=O)O)C(=O)O)N.Cl

Pomaglumetad methionil hydrochloride

CAS: 635318-26-2

Pomaglumetad methionil hydrochloride

Fórmula: C₁₂H₁₉ClN₂O₇S₂

Pureza: ≥98%

Peso molecular: 402.87

Ref: 54-BUP01339

Pomaglumetad methionil (hydrochloride)

CAS: 635318-26-2

Ref: IN-DA00EKNZ

Pomaglumetad methionil hydrochloride

CAS: 635318-26-2

Pomaglumetad methionil hydrochloride is a peptide that is an activator of the GABA receptor. It is an inhibitor of voltage-gated ion channels, which are responsible for the generation and propagation of action potentials in neurons. Pomaglumetad methionil hydrochloride is also a ligand for the GABA receptor and has been shown to inhibit protein interactions with a number of receptors, including the NMDA receptor, glycine receptor, and serotonin receptors. This drug has not been shown to have any pharmacological effects.

Fórmula: C₁₂H₁₉ClN₂O₇S₂

Pureza: Min. 95%

Peso molecular: 402.9 g/mol

Ref: 3D-KAB31826

Pomaglumetad methionil hydrochloride

CAS: 635318-26-2

LY2140023 hydrochloride: oral methionine prodrug of LY404039, a selective mGlu2/3 agonist, studied for schizophrenia.

Fórmula: C₁₂H₁₉ClN₂O₇S₂

Pureza: 98.57%

Forma y color: Solid

Peso molecular: 402.87

Ref: TM-T61972